Literature DB >> 35436323

Growth Hormone, Not IGF-1 Is the Key Longevity Regulator in Mammals.

Holly M Brown-Borg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35436323      PMCID： PMC9434454          DOI： 10.1093/gerona/glac092

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN： 1079-5006            Impact factor:   6.591


× No keyword cloud information.
  85 in total

1.  Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene.

Authors:  Manuel H Aguiar-Oliveira; Francielle T Oliveira; Rossana M C Pereira; Carla R P Oliveira; Amanda Blackford; Eugenia H O Valenca; Elenilde G Santos; Miburge B Gois-Junior; Rafael A Meneguz-Moreno; Vanessa P Araujo; Luis A Oliveira-Neto; Roque P Almeida; Mário A Santos; Natalia T Farias; Debora C R Silveira; Gabriel W Cabral; Flavia R Calazans; Juliane D Seabra; Tiago F Lopes; Endrigo O Rodrigues; Livia A Porto; Igor P Oliveira; Enaldo V Melo; Marco Martari; Roberto Salvatori
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

2.  Dwarf mice and the ageing process.

Authors:  H M Brown-Borg; K E Borg; C J Meliska; A Bartke
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

3.  Longevity of the hypopituitary patients from the island Krk: a follow-up study.

Authors:  Ciril Krzisnik; Snjezana Grgurić; Katarina Cvijović; Zvi Laron
Journal:  Pediatr Endocrinol Rev       Date:  2010-06

4.  Reduced insulin/IGF-1 signalling and human longevity.

Authors:  Diana van Heemst; Marian Beekman; Simon P Mooijaart; Bastiaan T Heijmans; Bernd W Brandt; Bas J Zwaan; P Eline Slagboom; Rudi G J Westendorp
Journal:  Aging Cell       Date:  2005-04       Impact factor: 9.304

5.  Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies.

Authors:  Rachel Steuerman; Orit Shevah; Zvi Laron
Journal:  Eur J Endocrinol       Date:  2011-02-03       Impact factor: 6.664

6.  Normal growth and development in the absence of hepatic insulin-like growth factor I.

Authors:  S Yakar; J L Liu; B Stannard; A Butler; D Accili; B Sauer; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 7.  Growth hormone and adipose tissue: beyond the adipocyte.

Authors:  Darlene E Berryman; Edward O List; Lucila Sackmann-Sala; Ellen Lubbers; Rachel Munn; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2011-04-05       Impact factor: 2.372

8.  Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span.

Authors:  Karen T Coschigano; Amy N Holland; Markus E Riders; Edward O List; Allan Flyvbjerg; John J Kopchick
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

Review 9.  LESSONS FROM 50 YEARS OF STUDY OF LARON SYNDROME.

Authors:  Zvi Laron
Journal:  Endocr Pract       Date:  2015-09-24       Impact factor: 3.443

10.  The GH receptor exon 3 deletion is a marker of male-specific exceptional longevity associated with increased GH sensitivity and taller stature.

Authors:  Danny Ben-Avraham; Diddahally R Govindaraju; Temuri Budagov; Delphine Fradin; Peter Durda; Bing Liu; Sandy Ott; Danielle Gutman; Lital Sharvit; Robert Kaplan; Pierre Bougnères; Alex Reiner; Alan R Shuldiner; Pinchas Cohen; Nir Barzilai; Gil Atzmon
Journal:  Sci Adv       Date:  2017-06-16       Impact factor: 14.136
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.